Production (Stage)
Sarepta Therapeutics, Inc.
SRPT
$37.60
-$1.01-2.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -61.41% | 13.05% | -17.95% | 5.01% | -17.03% |
| Total Receivables | 11.51% | 25.92% | 31.54% | -6.47% | -4.03% |
| Inventory | 25.53% | 32.52% | 16.49% | 30.06% | 15.69% |
| Prepaid Expenses | -4.44% | -2.77% | -7.88% | -0.22% | 24.14% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -25.60% | -22.81% | 20.16% | 25.91% | 113.57% |
| Total Current Assets | -20.85% | 14.45% | 0.06% | 8.88% | -4.44% |
|
|
|||||
| Total Current Assets | -20.85% | 14.45% | 0.06% | 8.88% | -4.44% |
| Net Property, Plant & Equipment | 3.89% | 9.39% | 11.62% | 6.56% | 5.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.56% | -2.48% | -2.41% | -2.34% | -2.33% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.76% | -6.51% | -16.66% | -2.90% | 7.41% |
| Total Assets | -12.56% | 10.09% | 5.13% | 6.20% | -1.23% |
|
|
|||||
| Total Accounts Payable | -27.20% | 80.55% | 10.57% | 17.35% | -44.50% |
| Total Accrued Expenses | -26.02% | 11.57% | 4.94% | 32.12% | -21.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.25% | -87.81% | 0.23% | -10.85% | 15.52% |
| Total Finance Division Other Current Liabilities | -1.74% | 2.77% | -4.06% | 11.27% | 29.01% |
| Total Other Current Liabilities | -1.74% | 2.77% | -4.06% | 11.27% | 29.01% |
| Total Current Liabilities | -17.23% | 4.60% | 1.60% | 13.11% | -6.88% |
|
|
|||||
| Total Current Liabilities | -17.23% | 4.60% | 1.60% | 13.11% | -6.88% |
| Long-Term Debt | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.75% | 13.21% | 18.39% | 2.50% | -0.61% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.22% | 0.20% | -1.81% | -0.11% | -20.37% |
| Total Liabilities | -4.63% | 2.38% | 1.35% | 3.71% | -5.91% |
|
|
|||||
| Common Stock & APIC | 1.08% | 2.69% | 1.95% | 2.04% | 1.27% |
| Retained Earnings | -10.63% | 3.64% | 0.76% | 0.15% | 0.81% |
| Treasury Stock & Other | 115.60% | -109.71% | 317.96% | -49.06% | -175.27% |
| Total Common Equity | -25.20% | 25.11% | 13.37% | 12.06% | 11.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.20% | 25.11% | 13.37% | 12.06% | 11.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.20% | 25.11% | 13.37% | 12.06% | 11.85% |
|
|
|||||